The Government’s medicines watchdog has called on pharmacists to rectify a problem with the patient information leaflet (PIL) in some packs of Zoledronic acid 5mg solution for infusion.
Some packs of the drug – used to treat bone diseases like osteoporosis – manufactured by Ranbaxy UK mistakenly contain the PIL for Temozolomide 180mg capsules instead of the correct one, the Medicines and Healthcare products Regulatory Agency (MHRA) warned today (4 April).
Pharmacists should check packs of the affected batch contains the right PIL and replace it with the correct one if they find packs that do not, the MHRA said. The correct PIL can be downloaded here.
The affected batch is:
|Batch Number||Expiry Date||Pack Size||First Distributed|
|JKT1576A||30/04/2020||1 x 100ml||12th October 2018|
Those with any enquiries should contact the Ranbaxy/Sun Pharmaceuticals customer services team on 020 8848 5050 or email Cserv.firstname.lastname@example.org